Anemoside B4 is primarily studied for its anti-inflammatory and neuroprotective properties. It has shown potential in modulating pathways involved in inflammatory responses, making it a candidate for research in treating neurodegenerative conditions such as Alzheimer's disease. The compound may help reduce neuroinflammation and oxidative stress, both of which are key factors in neuronal damage. It is also being investigated for its ability to improve cognitive function in animal models, suggesting possible applications in managing cognitive impairments. Additionally, Anemoside B4 exhibits protective effects on the blood-brain barrier, which could be beneficial in stroke and other cerebrovascular diseases. Due to its natural origin and observed low toxicity, it is considered a promising lead compound for developing herbal-based therapeutics, particularly in traditional medicine formulations targeting brain health and chronic inflammation.